Prazosin Hydrochloride

Prazosin Hydrochloride

Prazosin is an alpha-blocker that causes a decrease in total peripheral resistance and is used to treat hypertension. Prazosin is marketed by Pfizer and was initially approved by the FDA in 1988 It belongs to the class of drugs known as alpha-1 antagonists Label.

Systematic name

2-[4-(furan-2-carbonyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine

Brand name(s)

Minipress, Minizide

Therapeutic category

Anti-hypertensive

Available formulations

Solid

Approvals

USDMF

EU-WC

Do you have
a question?
lets Have
a Talk

Nuraychemicals is a pure-play API manufacturer with a diverse portfolio of capabilities in delivering efficiencies to generic players globally. Founded in 2012 by a team with vast experience across the pharmaceutical value chain, the company is on a mission to become the most preferred partner for pharmaceuticals.